«Treatment of Resistant and Refractory Hypertension». Circ. Res.124 (7): 1061–1070. March 2019. doi:10.1161/CIRCRESAHA.118.312156. PMID30920924. «A long-acting thiazide-like diuretic, specifically chlorthalidone, if available, is recommended over hydrochlorothiazide (HCTZ) given its superior efficacy and clear benefit demonstrated in multiple outcome studies of hypertension... However, chlorthalidone use is more frequently associated with adverse metabolic effects, particularly hypokalemia and hyponatremia, compared with HCTZ.».
«Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark». J. Am. Acad. Dermatol.78 (4): 673–681.e9. April 2018. doi:10.1016/j.jaad.2017.11.042. PMID29217346.
«Hydrochlorothiazide». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Μαΐου 2017. Ανακτήθηκε στις 30 Νοεμβρίου 2016.
«Treatment of Resistant and Refractory Hypertension». Circ. Res.124 (7): 1061–1070. March 2019. doi:10.1161/CIRCRESAHA.118.312156. PMID30920924. «A long-acting thiazide-like diuretic, specifically chlorthalidone, if available, is recommended over hydrochlorothiazide (HCTZ) given its superior efficacy and clear benefit demonstrated in multiple outcome studies of hypertension... However, chlorthalidone use is more frequently associated with adverse metabolic effects, particularly hypokalemia and hyponatremia, compared with HCTZ.».
«Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark». J. Am. Acad. Dermatol.78 (4): 673–681.e9. April 2018. doi:10.1016/j.jaad.2017.11.042. PMID29217346.
«Treatment of Resistant and Refractory Hypertension». Circ. Res.124 (7): 1061–1070. March 2019. doi:10.1161/CIRCRESAHA.118.312156. PMID30920924. «A long-acting thiazide-like diuretic, specifically chlorthalidone, if available, is recommended over hydrochlorothiazide (HCTZ) given its superior efficacy and clear benefit demonstrated in multiple outcome studies of hypertension... However, chlorthalidone use is more frequently associated with adverse metabolic effects, particularly hypokalemia and hyponatremia, compared with HCTZ.».
«Hydrochlorothiazide». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Μαΐου 2017. Ανακτήθηκε στις 30 Νοεμβρίου 2016.